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SUMMARY 
 
Arabinan polysaccharide side-chains are present in both Mycobacterium tuberculosis and 
Corynebacterium glutamicum in the heteropolysaccharide arabinogalactan (AG), and in 
M. tuberculosis in the lipoglycan, lipoarabinomannan (LAM). Herein, we show by 
quantitative sugar and glycosyl linkage analysis that C. glutamicum possesses a much 
smaller LAM version, Cg-LAM, characterised by single t-Araf residues linked to the 
?(1?6)-linked mannan backbone. MALDI-TOF MS showed an average molecular 
weight of 13 800-15 400 Da for Cg-LAM. The biosynthetic origin of Araf residues found 
in the extracytoplasmic arabinan domain of AG and LAM is well known to be provided 
by decaprenyl-monophosphoryl-D-arabinose (DPA). However, the characterisation of 
LAM in a C. glutamicum::ubiA mutant devoid of prenyltransferase activity and devoid of 
DPA-dependent arabinan deposition into AG, revealed partial formation of LAM, albeit 
with a slightly altered molecular weight. These data suggest that in addition to DPA 
utilisation as an Araf donor, alternative pathways exist in Corynebacterianeae for Araf 
delivery, possibly via an unknown sugar nucleotide. 
 
3 
INTRODUCTION 
 
The Corynebacterianeae represent a distinct and unusual group within Gram-positive 
bacteria, with the most prominent members being the human pathogens Mycobacterium 
tuberculosis and Mycobacterium leprae (Bloom & Murray, 1992). In addition, non-
pathogenic bacteria also belong to this taxon, such as Corynebacterium glutamicum, 
which is used in the industrial production of amino acids (Sahm et al., 2000) . These 
bacteria collectively belong to the same sub-order, and share a similar genome, cell 
envelope and corresponding cell wall biosynthetic enzymes (Dover et al., 2004; 
Stackebrandt et al., 1997). 
 
The characteristic cell envelope of this distinct group of bacteria contain mycolic acids, 
arabinogalactan (AG) and peptidoglycan, which are covalently linked to each other to 
form the mycolyl-arabinogalactan-peptidoglycan (mAGP) complex (Besra et al., 1995; 
Brennan & Nikaido, 1995; Brennan, 2003; Daffé et al., 1990; Dmitriev et al., 2000; 
Dover et al., 2004; McNeil et al., 1990; McNeil et al., 1991). In addition, they also 
possess an array of cell wall associated glycolipids, such as phosphatidyl-myo-inositol 
(PI), phosphatidyl-myo-inositol mannosides (PIMs) and the lipoglycans, lipomannan 
(LM) and lipoarabinomannan (LAM) (Brennan & Ballou, 1967; Brennan & Ballou, 
1968; Chatterjee et al., 1991; Chatterjee et al., 1993; Guerardel et al., 2002; Hill & 
Ballou, 1966; Khoo et al., 1995). As a result, arabinose is present in two polysaccharides 
with markedly different structures. Interestingly, the occurrence of arabinosyl-containing 
glycoconjugates in bacteria
 
(Brennan & Nikaido, 1995), plants (Fincher et al., 1983),
 
and 
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protozoan parasites (Dobson et al., 2003; Goswami et al., 2006; Guha-Niyogi et al., 
2001; Previato et al., 1982; Xavier Da Silveira et al., 1998), and their absence in 
mammalian
 
cells is well known. Moreover, Corynebacterianeae arabinan is an extremely 
complex homopolymer of D-arabinofuranose (D-Araf) residues based on discrete 
structural motifs, however the complete structures and biosynthesis of these polymers is 
still to be established. 
 
For LAM biosynthesis we initially proposed the following biosynthetic pathway 
PI?PIM?LM?LAM (Besra et al., 1997) in M. tuberculosis, which is now largely 
supported by biochemical and genetic evidence (Gurcha et al., 2002; Kordulakova et al., 
2002; Kremer et al., 2002; Schaeffer et al., 1999). PimA catalyses the addition of Manp 
provided by GDP-Mannose to the 2-position of the myo-inositol of PI to form PIM1 
(Kordulakova et al., 2002), whereas PimB might be responsible for the addition of a 
second Manp to the 6-position to yield Ac1PIM2 (Schaeffer et al., 1999; Tatituri et al., 
2007). PimC has been demonstrated to allow further mannosylation to Ac1PIM3 (Kremer 
et al., 2002) and more recently, PimE has been shown to involved in the biosynthesis of 
Ac1PIM5 (Morita et al., 2006). It has been proposed that PIM4 is the direct precursor of 
LM, characterised by a linear ?(1?6)-linked mannan backbone linked with ?(1?2) 
mannopyranose side chains generated through a mannosyltransferase encoded by Rv2181 
(Kaur et al., 2006). LM is then further glycosylated with arabinan to produce LAM, and 
finally ‘mannose-capped’ to produce ManLAM, a process initiated by the capping 
enzyme encoded by Rv1635c (Dinadayala et al., 2006). For the addition of arabinose 
residues into mycobacterial LAM, EmbC is required (Berg et al., 2005; Shi et al., 2006; 
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Zhang et al., 2003), whereas AftA, EmbA and EmbB perform arabinan polymerisation in 
AG (Alderwick et al., 2006b; Belanger et al., 1996; Escuyer et al., 2001). In contrast, C. 
glutamicum possesses a singular Emb, and an AftA orthologue, which are used in AG 
biosynthesis (Alderwick et al., 2005; Alderwick et al., 2006b; Seidel et al., 2007). It is 
interesting to note that the arabinan domains of AG and LAM utilise several different 
Araf linkages, which suggests that additional arabinofuranosyltransferases must be 
required to form AG and LAM, and still remain to be identified in Corynebacterianeae. 
 
It has been shown that the activated Araf sugar donor in Corynebacterianeae is 
decaprenyl-monophosphoryl-D-arabinose (DPA) (Wolucka et al., 1994). It was also 
proposed that decaprenyl-monophosphoryl-D-ribose (DPR) could be an additional 
precursor involved in arabinan synthesis, via a 2’-epimerase (Wolucka & de Hoffmann, 
1995). Recently, it was shown that 5-phosphoribofuranose pyrophosphate (pRpp) is 
converted
 
to decaprenyl-monophosphoryl-5-phosphoribose (DPPR) via a 5-phospho-?-D-
ribose-1-diphosphate-decaprenyl-phosphate 5-phosphoribosyltransferase, (UbiA; 
Rv3806c and NCgl2781 in M. tuberculosis and C. glutamicum, respectively) (Huang et 
al., 2005), which is then dephosphorylated
 
to form DPR. DPR is then enzymatically 
oxidised to form a keto-intermediate, DPX, followed
 
by an enzymatic reduction to DPA 
(Mikusova et al., 2005). Additionally, disruption of ubiA in C. glutamicum, the first 
enzyme involved in the biosynthesis of DPA, resulted in a complete loss of cell wall 
arabinan (Alderwick et al., 2006a). To date, no sugar nucleotides of Araf have been 
identified. The key discovery that Araf residues in AG arise from DPA, also raised doubts 
whether mycobacteria neither produce nor require Araf sugar nucleotides. Herein, we 
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now clearly show that an ubiA disrupted mutant of C. glutamicum still produces a 
modified LAM variant (Cg-LAM), which is arabinosylated even in the absence of the 
sugar donor DPA (Alderwick et al., 2006a). Taken together, the data suggests that 
alternative pathways may exist in Corynebacterianeae, independent of DPA utilisation, 
specifically involved in arabinosylation events in Cg-LAM biosynthesis.  
7 
METHODS 
 
Strains, construction of plasmids and culture conditions. C. glutamicum ATCC 13032 
(the wild type strain, and referred for the remainder of the text as C. glutamicum) and 
Escherichia coli DH5?mcr were grown in Luria-Bertani (LB) broth (Difco) at 30 °C and 
37 °C, respectively. The C. glutamicum::ubiA mutant was grown on complex medium 
brain heart infusion (BHI) (Difco). Kanamycin and ampicillin were used at a 
concentration of 50 ?g ml-1. The vector used for inactivation of C. glutamicum::ubiA was 
pCg::ubiA. It contained an internal ubiA-fragment of 321 bp amplified with the primer 
pairs ATC TTC AAC CAG CGC ACG ATC and AAT ATC GAT CAC TGG CAT GTG, 
which was ligated into the SmaI site of the non-replicative vector pK18mob to yield 
pCg::ubiA. To enable chromosomal inactivation of ubiA, pCg::ubiA was introduced into 
C. glutamicum by electroporation (Alderwick et al., 2005). 
 
Extraction and purification of lipoglycans. Purification procedures were adapted from 
protocols established for the extraction and purification of mycobacterial lipoglycans 
(Nigou et al., 1999). Briefly, 10 g of cells grown to and absorbance at 600 nm of 1.0, 
were delipidated at 60 
o
C by using 500 ml CHCl3/CH3OH (1:1, v/v). The delipidated cells 
were resuspended in deionized water and disrupted by probe sonication (MSE Soniprep 
150, 12 micron amplitude, 60 s ON, 90 s OFF for 10 cycles, on ice) and the cell debris 
refluxed 5 times with 100 ml of C2H5OH/H20 (1:1, v/v) at 68 °C, for 12 h intervals. The 
cell debris was removed by centrifugation and the supernatant containing lipoglycans, 
neutral glycans and proteins dried. The dried supernatant was then treated with a hot 80 
8 
% (w/w) phenol–H2O, biphasic wash at 70 °C for 1 h, followed by several protease 
treatments and the lipoglycan fraction recovered following extensive dialysis against 
deionized water (Nigou et al., 1999). 
 
The crude lipoglycan extract was resuspended in buffer A (50 mM ammonim acetate and 
15 % propan-1-ol) and subjected to Octyl-Sepharose CL-4B hydrophobic interaction 
chromatography (2.5 cm x 50 cm) as previously reported (Leopold & Fischer, 1993). The 
column was initially washed with 4 column volumes of buffer A to ensure removal of 
neutral glycans followed by an increasing gradient of propan-1-ol ranging from 25-65 % 
keeping the concentration of ammonium acetate constant. The eluates were collected and 
extensively dialysed against deionized water and concentrated to approximately 1 ml and 
precipitated using 5 ml of C2H5OH and the sample freeze-dried using a Savant SpeedVac. 
The freeze-dried sample containing the retained material from the hydrophobic 
interaction column was then re-suspended in buffer B (0.2 M NaCl, 0.25 % sodium 
deoxycholate (w/v), 1 mM EDTA and 10 mM Tris-HCl, pH 8) to a final concentration of 
200 mg ml
-1
. The sample was gently mixed and left to incubate for 48 h at room 
temperature. The sample was then loaded onto a Sephacryl S-200 column (2.5 cm x 50 
cm) previously equilibrated with buffer B. The sample was washed with 400 ml of buffer 
C (0.2 M NaCl, 1 mM EDTA and 10 mM Tris-HCl, pH 8) at a flow rate of 3 ml h
-1
, 
collecting 1.5 ml fractions using a Bio-Rad auto-sampler. The fractions were monitored 
by SDS-PAGE  using either a silver stain utilising periodic acid and silver nitrate (Hunter 
et al., 1986) or a Pro-Q emerald glycoprotein stain (Invitrogen) and individual fractions 
pooled and dialysed extensively against buffer C for 72 h with frequent changes. The 
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samples were further dialysed against deionized water for 48 h with frequent changes of 
deionized water, lyophilised and stored at - 20ºC. 
 
Glycosyl composition and linkage analysis of lipoglycans by alditol acetates. 
Lipoglycans from wild type C. glutamicum and the C. glutamicum::ubiA mutant were 
hydrolysed using 2 M trifluoroacetic acid (TFA), reduced with NaBD4, and the resultant 
alditols were per-O-acetylated and examined by Gas Chromatography (GC) (Tatituri et 
al., 2007). Lipoglycans (2 mgs) were per-O-methylated using dimethyl sulfinyl carbanion 
as described previously (Alderwick et al., 2005; Besra et al., 1995; Daffé et al., 1990). In 
this procedure, lipoglycan samples (2 mgs) were resuspended in 0.5 ml dimethyl 
sulphoxide (anhydrous) and 100 μl of 4.8 M dimethyl sulfinyl carbanion. The reaction 
mixture was stirred for 1 h and then iodomethane (50 μl) was slowly added and the 
suspension stirred for 1 h, this process was repeated for a total of three times. The 
reaction mixture was then diluted with an equal volume of water, dialysed against 
deionized water and dried. The resulting retentate was applied to a pre-equilibrated C18 
Sep-Pak cartridge and initially washed with 10 ml water, 10 ml 20 % acetonitrile, and the 
per-O-methylated lipoglycan eluted with 2 ml acetonitrile and 2 ml ethanol. After drying 
the combined organic eluate under nitrogen, the per-O-methylated lipoglycan was 
hydrolysed using 250 μl of 2 M TFA at 120 °C for 2 h. The resulting hydrolysate was 
reduced with NaBD4, per-O-acetylated and examined by Gas Chromatography/Mass 
Spectrometry (GC/MS) (Tatituri et al., 2007). Per-O-methylation of lipoglycans for 
Matrix-assisted Laser Desorption Ionisation-Mass Spectrometry (MALDI-MS) analysis 
was performed as described previously (Dell et al., 1993). Briefly, 1 ml of a dimethyl 
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sulfoxide/NaOH slurry was added followed by 0.5 ml of iodomethane. The reaction 
mixture was vigorously shaken for 10 min at room temperature and the reaction 
quenched with 1 ml of water. Per-O-methylated samples were then extracted into 
chloroform (1 ml) and washed several times with water before drying under a stream of 
nitrogen. 
 
GC and GC/MS analysis. Analysis of partially per-O-methylated, per-O-acetylated 
alditol acetate sugar derivatives was performed on a CE Instruments ThermoQuest Trace 
GC 2000. Samples were injected in the split mode. The column used was a DB225 
(Supelco). The oven was programmed to hold at an isothermal temperature of 275 °C for 
a run time of 15 min. GC/MS was carried out on a BPX5 column (Supelco) and a 
Finnigan Polaris/GCQ PlusTM, as described previously (Besra et al., 1995; Daffé et al., 
1990). GC/MS analysis of alditol acetate sugar derivatives was performed on a Perkin 
Elmer Clarus 500 Instrument. Samples were injected in the splitless mode. The column 
used was a RTX-5 (30 m x 0.25 mm internal diameter, Restek Corp.). Initial temperature 
was set at 60 °C then ramped to 300 °C at 8 °C /min. 
 
NMR Spectroscopy. NMR spectra of lipoglycans were recorded on a Bruker DMX-500 
equipped, with a double resonance (1H/X)-BBi z-gradient probe head. All samples were 
exchanged in D2O (D, 99.97% from Euriso-top, Saint-Aubin, France), with intermediate 
lyophilisation, and then dissolved in 0.5 ml D2O and analysed at 313K. The 
1
H and 
13
C 
NMR chemical shifts were referenced relative to internal acetone at 2.225 and 34.00 
ppm, respectively. All the details concerning NMR sequences used and experimental 
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procedures were described in previous studies (Gilleron et al., 1999; Gilleron et al., 2000; 
Nigou et al., 1999). 
 
MALDI-MS Analysis. MALDI-MS was performed using a PerSeptive Biosystems 
Voyager DE
®
 STR mass spectrometer. Native lipogycans were dissolved in methanol/H2O 
50:50 and 1 μl of the sample was loaded onto a metal plate. After evaporation 1 μl of the 
matrix 2,5-dihydroxybenzoic acid was added on the spot. Samples were analysed using the 
linear negative mode. Per-O-methylated samples were dissolved in methanol/H2O (80:20, 
v/v) and analysed in the linear positive mode using 2,5-dihydroxybenzoic acid as matrix. 
Sequazyme peptide mass standards were used as external calibrants (Applied Biosystems, 
Foster City, CA). 
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RESULTS 
 
Disruption of Cg-ubiA.  The ubiA gene product was shown in prior work to synthesise 
DPPR, which is converted to DPA, thus supplying the substrate for the “priming" 
arabinosyltransferase AftA (Alderwick et al., 2006b). These initial Araf residues “prime” 
the galactan backbone for further attachment of ?(1?5) linked Araf residues. These 
reactions require the arabinofuranosyltransferase activities of Mt-EmbA and Mt-EmbB, or 
Cg-Emb, respectively, and also the utilisation of DPA (Alderwick et al., 2005; Escuyer et 
al., 2001; Seidel et al., 2007), to eventually result in mature AG. In light of our present 
studies demonstrating the occurrence of Cg-LAM we inactivated the mycobacterial 
orthologue of C. glutamicum, NCgl2781, by transforming the wild type to kanamycin 
resistance conferred by the vector borne aph gene product of pCg::ubiA with a view of 
generating a clear C. glutamicum LM-only phenotype. The vector, as previously described 
(Alderwick et al., 2005), was integrated into the chromosomal ubiA gene, thus disrupting 
ubiA, as confirmed by two independent PCR analyses with two different primer pairs 
(Alderwick et al., 2005). As expected, the resulting strain C. glutamicum::ubiA exhibited a 
strong reduced growth (Alderwick et al., 2006a). 
 
Purification of lipoglycans from C. glutamicum and C. glutamicum::ubiA.  Analysis of 
the crude phenol-extracted lipoglycans from C. glutamicum (Fig. 1A) and C. 
glutamicum::ubiA (Fig. 1B) visualised on SDS-PAGE revealed two closely migrating 
lipoglycans. A two-step purification protocol was performed to fractionate the crude 
lipoglycans. In the first step, the neutral glycans and nucleic acids were eliminated by using 
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an octyl-Sepharose CL-4B column (Amersham Biosciences). In the second step, the 
lipoglycans were individually purified using a Sephacryl S-200 column (Amersham 
Biosciences). Fractions containing the lipoglycans were monitored by SDS-PAGE stained 
with either silver nitrate or Pro-Q emerald glycoprotein stains and pooled accordingly to 
afford lower (1) and upper (2) lipoglycans (Fig. 1A and B). 
 
General structural features of lipoglycans from C. glutamicum and C. 
glutamicum::ubiA.  The lower lipoglycan (1) from both C. glutamicum and C. 
glutamicum::ubiA were similar and exhibited the basic components of a structure related to 
mycobacterial LM (now termed Cg-LM) and contained solely mannopyranose (Manp). Per-
O-methylation analysis of Cg-LM from both strains indicated the presence of t-Manp, 2-
Manp, 6-Manp and 2,6-Manp residues (Tatituri et al., 2007). GC analysis of the total acid 
hydrolysed upper lipoglycan (2) from C. glutamicum contained arabinose and mannose in a 
ratio (23:77) and was related to mycobacterial LAM (Fig. 2A). In addition, per-O-
methylation analysis of wild type Cg-LAM indicated the presence of t-Araf, t-Manp, 2-
Manp, 6-Manp and 2,6-Manp residues (Fig. 3A). Interestingly, Cg-LAM of the wild-type 
strain was previously shown to be composed of a PI anchor linked to an ?(1?6)Manp 
backbone substituted at most of the O-2 positions by the structural motifs t-Araf, t-Manp, t-
Araf(1?2)-Manp and t-Manp(1?2)-Manp units (Fig. 4E) (Tatituri et al., 2007). 
Accordingly, the 1D 
1
H-NMR anomeric region (Fig. 4A) exhibited a complex pattern of 
overlapping resonances corresponding to Araf and Manp units. The different spin systems 
were characterised by 
1
H-
13
C HMQC NMR (Fig. 4B) and anomeric resonances were 
attributed as follows: ?H1C1 ? 5.20/112.2 (I1) to two overlapping t-Araf units (see below) and 
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5.13/112.0 (II1) to a third t-Araf unit,? 5.06/105.2 (III1) to t-Manp units,? 5.12/101.4 (IV1), 
5.07/101.7 (V1) and 5.04/101.9 (VI1) to 2,6-Manp units, 5.06/105.2 (VII1) to 6-Manp units 
and 5.00/104.9 (VIII1) to 2-Manp units. 
 
Our previous experiments demonstrated that the C. glutamicum::ubiA mutant failed to 
synthesise DPA (Alderwick et al., 2006a) and possessed an arabinan deficient cell wall 
phenotype (Alderwick et al., 2005). As a consequence, we anticipated that the Cg-LAM 
from the mutant would be devoid of arabinose. Surprisingly, glycosyl compositional 
analysis of Cg-LAM from the C. glutamicum::ubiA mutant contained arabinose, albeit 
substantially reduced, and mannose in a ratio (4.5:95.5) (Fig. 2B). In addition, per-O-
methylation analysis of Cg-LAM from the mutant indicated the presence of t-Araf, t-
Manp, 2-Manp, 6-Manp and 2,6-Manp, although, the relative abundance of t-Araf 
residues was reduced (Fig. 3B). In agreement with the glycosyl compositional and 
linkage analysis data indicating a reduced amount of t-Araf units, the 1D 
1
H anomeric 
region of Cg-LAM from the glutamicum::ubiA mutant (Fig. 4C) was simpler than that 
observed for Cg-LAM from wild type C. glutamicum (Fig. 4A). Resonance I1 
corresponding to a t-?-Araf unit was dramatically reduced, suggesting two overlapping t-
Araf signals. This was further confirmed by 
1
H-
13
C HMQC analysis (Fig. 4D). Indeed, 
the relative intensity of the correlation at ?H1C1? 5.20/112.2 (I1) was much weaker and 
correlation at ?H1C1  5.13/112.0 (II1) of the third t-Araf residue was absent.  
 
The native Cg-LAMs from wild type C. glutamicum and the C. glutamicum::ubiA mutant 
were analysed by MALDI TOF MS. MALDI spectra were performed in the linear 
15 
negative mode. The mass spectra show broad unresolved molecular ion envelopes due to 
the heterogeneity of the Cg-LAMs and the relatively low resolution of this type of mass 
spectrometry. The native Cg-LAM from wild type C. glutamicum shows an average 
molecular weight of around 15 400 Da (Fig. 5A). The native Cg-LAM from the C. 
glutamicum::ubiA mutant shows a somewhat lower average molecular weight in the 
region of 13 900 Da (Fig. 5B). Samples of Cg-LAM from wild type C. glutamicum and 
C. glutamicum::ubiA were subjected to per-O-methylation and analysed by MALDI TOF 
MS (data not shown). Per-O-methylation replaces fatty acyl substituents with methyl 
groups as well as methylating all the free hydroxyl groups. The average molecular weight 
of the derivatised Cg-LAM from wild type C. glutamicum was observed around 15 600 
Da, whilst the molecular weight of the corresponding Cg-LAM from C. 
glutamicum::ubiA was observed around 15 200 Da.  
 
Altogether, these data indicate that the C. glutamicum::ubiA mutant produces a slightly 
truncated Cg-LAM with a severe reduction in t-Araf content but maintaining and 
possibly extending its mannan core. In addition, the presence of UbiA and the 
biosynthesis of DPA, appears essential for the higher arabinosylation of Cg-LAM. 
Moreover, these findings suggest that arabinose deposition in the C. glutamicum::ubiA 
mutant is a result of incorporation of t-Araf through another arabinose substrate, and one 
which is not DPA dependent. 
16 
DISCUSSION 
 
Understanding the biosynthesis of mycobacterial arabinan is paramount to identifying 
potential new drug targets for the treatment of tuberculosis. However, as discussed earlier 
a complete understanding of these pathways is far from clear. In this respect, C. 
glutamicum is a useful tool in understanding mycobacterial cell wall biosynthesis, since 
this organism possesses the core structural elements in Corynebacterianeae with few 
gene duplications, and deletion of orthologous genes which is often lethal in 
mycobacterial species is possible (Alderwick et al., 2005; Alderwick et al., 2006b; Gande 
et al., 2004). Specifically, the deletion of the DPA requiring arabinosyltransferase Emb in 
C. glutamicum resulted in a strongly abrogated arabinan domain of AG (Alderwick et al., 
2005), and deletion of AftA also disabled attachment of the remaining singular t-Araf 
residues to galactan (Alderwick et al., 2006b). Furthermore, the loss of DPA synthesis in 
a C. glutamicum::ubiA mutant also resulted in the full loss of the arabinan domain in 
mature AG (Alderwick et al., 2005). In contrast, Cg-LM and Cg-LAM isolated from the 
corresponding C. glutamicum?emb and ?aftA mutants were similar to the wild type 
glycans (data not shown). An absence of Araf residues was expected in Cg-LAM of the 
C. glutamicum::ubiA mutant. Strikingly, a total absence of arabinan was not observed 
(Fig. 2), thus requiring an alternative source and mechanism of addition of this sugar 
which may be attributed to the presence of an uncharacterised nucleotide sugar donor in 
Corynebacterineae.  
 
17 
In contrast to mycobacteria, parasites do synthesise and utilise a sugar nucleotide to 
provide an activated arabinose sugar donor. Schneider et al. (1994) characterised GDP-?-
D-Arap, the precursor of D-Ara in Leishmania major lipophosphoglycan. In 
trypanosomatids, this sugar nucleotide is believed to be synthesised in a two step process 
through the combined activities of an Ara-1-kinase and GDP-Ara pyrophosphorylase, 
whereby arabinose is phosphorylated to form arabinose 1-phosphate and then activated to
 
the nucleotide level by GDP-D-Arap pyrophosphorylase (Mengeling & Turco, 1999; 
Schneider et al., 1995). Compared with the many genes encoding glycosyltransferases in
 
prokaryotic and eukaryotic systems, very little is known about those that
 
encode 
arabinopyranosyltransferases. Dobson et al. (2003) identified two genes
 
(SCA1/2) 
encoding arabinosyltransferases mediating scAra capping, and recently it was 
demonstrated by heterologous expression that Leishmania SCA1 encodes an 
arabinopyranosyltransferase (Goswami et al., 2006). 
 
Glycosyltransferases belonging to one of the families, GT-A and GT-B, or both, may be 
responsible for the initial addition of t-Araf residues on to Cg-LAM in the absence of 
DPA. These enymes may be present on the cytoplasmic side of the membrane and 
probably aid in the transfer of t-Araf residues from a putative sugar nucleotide donor. 
These results could explain the presence of t-Araf in Cg-LAM, even though DPA 
biosynthesis has been completely abrogated in the C. glutamicum::ubiA mutant 
(Alderwick et al., 2005). The mechanism as to how these Araf residues are added is not 
clear. One possible explanation is that Araf residues from a nucleotide precursor are 
added in a step-wise fashion to Cg-LM on the cytoplasmic side to give motif-A proximal 
18 
to PI, and then this complex polysaccharide is then probably flipped on to the periplasmic 
side. It is thought that the flipping mechanism is a prerequisite for arabinosylation to 
occur outside of the membrane, where the arabinan and mannan domains are formed 
through specific GT-C glycosyltransferases, by the addition of either t-Araf and t-Manp 
residues, from DPA or decaprenyl-monophorphoryl-D-mannose (DPM) to give motif-B, 
C and D (Fig. 4E and Fig. 6) (Berg et al., 2007; Seidel et al., 2007; Tatituri et al., 2007). 
The biosynthetic origin of mycobacterial Araf residues is generally a poorly understood 
area. To date, no sugar nucleotides of Araf have been identified, and as a result, a number 
of theories regarding the generation of arabinan in mycobacteria have been put forward 
(Huang et al., 2005; Mikusova et al., 2005; Scherman et al., 1995; Scherman et al., 
1996). Depending on the organisation of the arabinan chains, it is speculated that five or 
six arabinofuranosyltransferases are required for arabinan biosynthesis in mycobacteria. 
In this regard, it is interesting to note that an M. smegmatis embC mutant (Escuyer et al., 
2001; Zhang et al., 2003) was found to be devoid of LAM but from the chemical 
analysis, the resulting LM precursor, possessed 2-3 Araf residues. The possibility exists 
that these residues are initially added via a non-DPA dependent glycosyltransferase and 
requires further investigation. 
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FIGURE LEGENDS 
 
Figure 1. Lipoglycan profiles of wild type C. glutamicum (A) and C. 
glutamicum::ubiA (B). Lipoglycans were analysed using SDS-PAGE and visualised 
using the Pro-Q emerald glycoprotein stain (Invitrogen) specific for carbohydrates. 
Individual lipoglycans (1 and 2) were purified as described in the methods section. 
Abbreviations: C: crude lipoglycan; M: molecular weight marker (kDa). 
 
Figure 2. Glycosyl compositional analysis of lipoglycan-2 from wild type C. 
glutamicum (A) and C. glutamicum::ubiA (B). Samples of individually purified 
lipoglycans (2) were hydrolysed with 2M TFA, reduced and per-O-acetylated. Alditol 
acetates were subjected to GC analysis. Peak area integration shows the arabinose content 
is 23 % in wild type C. glutamicum (Panel A) and 4.5% in the C. glutamicum::ubiA 
mutant (Panel B). Abbreviations: Ara, arabinose; Man, mannose. 
 
Figure 3. Glycosyl linkage analysis of per-O-methylated lipoglycan-2 from C. 
glutamicum (A) and C. glutamicum::ubiA (B). Lipoglycan-2 from C. glutamicum and 
C. glutamicum::ubiA were per-O-methylated, hydrolysed using 2M TFA, reduced, and 
per-O-acetylated. The resulting partially per-O-methylated and per-O-acetylated glycosyl 
derivatives were analysed by GC/MS as described previously (Alderwick et al., 2005). 
 
Figure 4. NMR characterisation of wild-type Cg-LAM (A, B), Cg-LAM from the 
UbiA mutant (C, D) and a structural representation of Cg-LAM (E). 1D 
1
H (A,C) 
27 
and 2D 
1
H-
13
C HMQC (B,D) NMR spectra of Cg-LAMs in D2O at 313K. Expanded 
regions (? 1H: 4.85-5.30) (A,C) and (? 1H: 4.85-5.30, ? 13C: 100-114) (B,D) are shown. 
Glycosyl residues are labelled in Roman numerals and their carbons and protons in 
Arabic. I, II, t-?-Araf; III, t-?-Manp; IV, V, VI, 2,6-?-Manp; VII, 6-?-Manp; VIII, 2-?-
Manp. Structural representation of Cg-LAM (Tatituri et al., 2007). Cg-LAM contains an 
(1?6)-Manp backbone almost completely substituted by t-Araf, t-Manp, t-Manp(1?2)-
Manp, and t-Araf(1?2)-Manp units. X, either a t-Araf or a t-Manp unit (E). 
 
Figure 5. MALDI-TOF MS spectra of Cg-LAM from wild type C. glutamicum (A) 
and C. glutamicum::ubiA (B). MALDI spectra were performed in the linear negative 
mode with delayed extraction using 2,5-dihydrobenzoic acid as matrix. 
 
Figure 6. Proposed biosynthetic pathway of Cg-LAM. The addition of the first Araf 
unit is thought to occur on the cytoplasmic side of the membrane by a GT-A/B 
glycosyltransferase (Liu & Mushegian, 2003). After transportation across the membrane 
by an unknown “flippase” enzyme, further elaboration of the lipoglycan then occurs 
through the addition of mannose and arabinose units catalysed by several GT-C 
glycosyltransferases utilising DPM and DPA, respectively (Berg et al., 2007; Seidel et 
al., 2007; Tatituri et al., 2007).
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